Literature DB >> 17494728

Ethical issues during the conduct of clinical trials.

Henry Silverman1.   

Abstract

While the focus of ethical clinical trial conduct has been on protocol review in advance of the research, there has been a recent emphasis on monitoring subject welfare during the conduct of research. The ethical conduct of a clinical trial does not end with the formulation of study design or the obtainment of a signature on the informed consent form. This article defines and describes the necessary monitoring responsibilities to ensure the adequate protection of the rights and welfare of human subjects and the four parties who share such responsibilities: the institutional review board, the data monitoring committee (or the data safety and monitoring board), the sponsor, and the investigator. This article also reviews the numerous challenges associated with monitoring--such as overlapping responsibilities, communication gaps, and lack of standards--and attempts to provide recommendations to address some of these issues.

Entities:  

Mesh:

Year:  2007        PMID: 17494728     DOI: 10.1513/pats.200701-010GC

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  4 in total

1.  Ethics committees in India: Facing the challenges!

Authors:  Rashmi Kadam; Shashikant Karandikar
Journal:  Perspect Clin Res       Date:  2012-04

Review 2.  Periodontal Research: Basics and beyond - Part II (Ethical issues, sampling, outcome measures and bias).

Authors:  Haritha Avula
Journal:  J Indian Soc Periodontol       Date:  2013-09

Review 3.  Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.

Authors:  Victoria Borg Debono; Lawrence Mbuagbaw; Lehana Thabane
Journal:  Trials       Date:  2017-03-09       Impact factor: 2.279

4.  Curricular adequacy on basics of clinical trials.

Authors:  Sonu Gupta; Ravinder Nath Bansal
Journal:  Indian J Pharmacol       Date:  2019 Mar-Apr       Impact factor: 1.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.